174 related articles for article (PubMed ID: 21148769)
1. Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats.
Kang KT; Sullivan JC; Spradley FT; d'Uscio LV; Katusic ZS; Pollock JS
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H718-24. PubMed ID: 21148769
[TBL] [Abstract][Full Text] [Related]
2. Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats.
Kang KT; Sullivan JC; Sasser JM; Imig JD; Pollock JS
Hypertension; 2007 Apr; 49(4):893-901. PubMed ID: 17309950
[TBL] [Abstract][Full Text] [Related]
3. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.
Sasser JM; Sullivan JC; Elmarakby AA; Kemp BE; Pollock DM; Pollock JS
Hypertension; 2004 May; 43(5):1080-5. PubMed ID: 14993198
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin and hypertension: more than an emigrating story.
Lin JY; Moens AL
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H715. PubMed ID: 21217060
[No Abstract] [Full Text] [Related]
5. Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice.
d'Uscio LV; Smith LA; Katusic ZS
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2227-34. PubMed ID: 21963838
[TBL] [Abstract][Full Text] [Related]
6. Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.
Giachini FR; Lima VV; Carneiro FS; Tostes RC; Webb RC
Hypertension; 2011 Mar; 57(3):655-63. PubMed ID: 21282562
[TBL] [Abstract][Full Text] [Related]
7. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Neves MF; Virdis A; Schiffrin EL
J Hypertens; 2003 Jan; 21(1):189-98. PubMed ID: 12544451
[TBL] [Abstract][Full Text] [Related]
8. Superoxide Dismutase Activity in Small Mesenteric Arteries Is Downregulated by Angiotensin II but Not by Hypertension.
Kang KT; Sullivan JC; Pollock JS
Toxicol Res; 2018 Oct; 34(4):363-370. PubMed ID: 30370011
[TBL] [Abstract][Full Text] [Related]
9. GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide.
Li L; Rezvan A; Salerno JC; Husain A; Kwon K; Jo H; Harrison DG; Chen W
Circ Res; 2010 Feb; 106(2):328-36. PubMed ID: 19926872
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) induced vascular relaxation in spontaneously hypertensive rats.
Zhang F; Tang H; Sun S; Luo Y; Ren X; Chen A; Xu Y; Li P; Han Y
Nitric Oxide; 2019 Jul; 88():1-9. PubMed ID: 30880106
[TBL] [Abstract][Full Text] [Related]
11. Dietary nitrate improves age-related hypertension and metabolic abnormalities in rats via modulation of angiotensin II receptor signaling and inhibition of superoxide generation.
Hezel M; Peleli M; Liu M; Zollbrecht C; Jensen BL; Checa A; Giulietti A; Wheelock CE; Lundberg JO; Weitzberg E; Carlström M
Free Radic Biol Med; 2016 Oct; 99():87-98. PubMed ID: 27474450
[TBL] [Abstract][Full Text] [Related]
12. Effects of Angiotensin-(1-7) and Angiotensin II on Acetylcholine-Induced Vascular Relaxation in Spontaneously Hypertensive Rats.
Zhang F; Xu Y; Pan Y; Sun S; Chen A; Li P; Bao C; Wang J; Tang H; Han Y
Oxid Med Cell Longev; 2019; 2019():6512485. PubMed ID: 31827689
[TBL] [Abstract][Full Text] [Related]
13. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
[TBL] [Abstract][Full Text] [Related]
14. Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation.
Inscho EW; Cook AK; Murzynowski JB; Imig JD
J Hypertens; 2004 Apr; 22(4):811-8. PubMed ID: 15126924
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.
Ramseyer VD; Ortiz PA; Carretero OA; Garvin JL
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F748-F754. PubMed ID: 26887831
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.
Hagihara GN; Lobato NS; Filgueira FP; Akamine EH; Aragão DS; Casarini DE; Carvalho MH; Fortes ZB
PLoS One; 2014; 9(8):e106029. PubMed ID: 25170617
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension.
Cervantes-Pérez LG; Ibarra-Lara Mde L; Escalante B; Del Valle-Mondragón L; Vargas-Robles H; Pérez-Severiano F; Pastelín G; Sánchez-Mendoza MA
Eur J Pharmacol; 2012 Jun; 685(1-3):108-15. PubMed ID: 22542661
[TBL] [Abstract][Full Text] [Related]
18. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
[TBL] [Abstract][Full Text] [Related]
20. Changes in NOS activity and protein expression during acute and prolonged ANG II administration.
Moreno C; López A; Llinás MT; Rodríguez F; López-Farré A; Nava E; Salazar FJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jan; 282(1):R31-7. PubMed ID: 11742820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
